The global Orthopedic Biomaterials market size is expected to be worth around US$ 23.10 billion by 2028, according to a new report by Vision Research Reports.
The global Orthopedic Biomaterials market size was valued at US$ 12.09 billion in 2020 and is anticipated to grow at a CAGR of 10.9% during forecast period 2021 to 2028.
Increasing incidence of degenerative joint disease and musculoskeletal disorders is the key factor driving the market. In addition, increasing geriatric population susceptible to orthopedic conditions arising due to low bone density and advancing bone related disorders is expected to boost the product demand over the forecast period.
Ceramics & bioactive glass was the dominant material type segment in 2018 on account of growing demand for these materials due to their high compression strength. In addition, ceramics & bioactive glass biomaterials are preferred over their counterparts as they have a high affinity to integrate with the surface material of the bone. However, polymer biomaterial segment is expected to witness the fastest CAGR from 2019 to 2025 owing to high usage of these materials for the reconstruction and fixation procedures of the spine, hip, and knee.
Orthopedic implants led the application segment in 2018 and are expected to remain dominant over the forecast period. Increasing number of trauma cases is one of the major factors driving the growth of this segment. segment is anticipated to witness the fastest CAGR of 10.8% from 2019 to 2025. Increasing adoption of biomaterials in various orthobiologics for the treatment of spinal and other reconstructive surgeries is anticipated to drive the growth of this segment.
Based on the material type, the market is classified into ceramics & bioactive glass, polymers, calcium phosphate cement, metal, and composites. The ceramics & bioactive glass segment led the market in 2020 owing to the increased adoption of ceramics in the repair of hard tissues in various procedures. On the other hand, the polymer segment is anticipated to witness the fastest CAGR from 2019 to 2025 on account of the extensive use of polymers as bone cement and load bearing surfaces for total joint arthroplasties. In addition, the availability of advanced polymers and biopolymers for various applications like orthobiologic and bio-resorbable tissue fixation has surged the demand for polymers globally.
On the basis of application, the market is segmented into orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. In 2020, orthopedic implants emerged as the dominant segment and is expected to maintain its dominance throughout the forecast period. Rising incidences of disc degenerative conditions and bone fractures coupled with increasing trauma cases are expected to boost the product demand in this segment.
The segment is expected to register the fastest CAGR of 10.12% over the forecast period owing to the increasing number of bone repair and reconstruction surgeries worldwide as a result of the rise in the obesity and trauma cases. According to the statistics published by the WHO, about 1.3 million people die each year due to road traffic crashes across the globe, out of which 93% of the total fatalities on the roads occur in low- and middle-income countries.
On the basis of region, the orthopedic biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the market in 2018 and is estimated to expand further at a lucrative CAGR over the forecast period. This growth can be attributed to the rise in the number of patients requiring knee replacement, reconstruction, and other joint-related orthopedic procedures. Quick adoption of advanced products for bone void filling and implant load-bearing purpose is anticipated to drive the regional market further.
Asia Pacific is expected to be the fastest-growing regional market at a CAGR of 11.18% over the forecast period. Key factors driving the regional market include the rising prevalence of bone degenerative diseases and bone disorders in low- and middle-income countries. Moreover, continuously increasing healthcare expenditure coupled with improving healthcare infrastructure is expected to serve as a high-impact rendering driver to the market in this region.
DSM Biomedical; Evonik Industries AG; Stryker Corp.; DePuy Synthes Inc.; Zimmer Biomet; Invibio Ltd.; Globus Medical; Exactech, Inc.; Matexcel; AdvanSource Biomaterials Corp.; CAM Bioceramics B.V.; and Heraeus Holding.
Material Type Outlook
Ceramics & Bioactive Glasses
Calcium Phosphate Cement
Bio-resorbable Tissue Fixation
The Orthopedic Biomaterials market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Orthopedic Biomaterials market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Orthopedic Biomaterials market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthopedic Biomaterials market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Orthopedic Biomaterials market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Orthopedic Biomaterials capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Orthopedic Biomaterials by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Orthopedic Biomaterials market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Orthopedic Biomaterials market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Orthopedic Biomaterials market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Orthopedic Biomaterials industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Orthopedic Biomaterials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Orthopedic Biomaterials market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Orthopedic Biomaterials market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Orthopedic Biomaterials market. These factors have benefited the growth of the global market for Orthopedic Biomaterials. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Orthopedic Biomaterials. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Orthopedic Biomaterials are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Respiratory Virus Infection Drugs Market (By Drug Type: Cough Suppressants, Antibiotics, Non-Steroidal Anti-Inflammatory Drugs [NSAIDS], Nasal Decongestants, and Others; By Infection Type, By Route of Administration, By Mode of Purchase, By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...